Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.5394
+0.0186 (3.57%)
At close: Sep 2, 2026, 4:00 PM EDT
0.5400
+0.0006 (0.11%)
After-hours: Sep 2, 2026, 4:35 PM EDT
Evogene Market Cap
Evogene has a market cap or net worth of $7.24 million as of September 2, 2026. Its market cap has decreased by -34.23% in one year.
Market Cap
7.24M
Enterprise Value
9.06M
1-Year Change
-34.23%
Ranking
Category
Stock Price
$0.54
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $7.24M, a decrease of -74.15%. That is a compound annual growth rate of -6.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 7.24M | -11.90% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Soligenix | 8.18M |
| Skye Bioscience | 7.97M |
| Alzamend Neuro | 7.84M |
| Bolt Biotherapeutics | 7.84M |
| Ensysce Biosciences | 7.55M |
| Acurx Pharmaceuticals | 7.38M |
| Creative Medical Technology Holdings | 7.25M |
| AIM ImmunoTech | 7.18M |